Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 04 2021
12 04 2021
Historique:
received:
14
01
2021
accepted:
22
03
2021
entrez:
13
4
2021
pubmed:
14
4
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Occupational and environmental associations with systemic sclerosis (SSc) have been confirmed; however, the association between aerosol components and mortality is uncertain. The study aimed to define the association between aerosol components and hospital mortality among Thai SSc patients. A study was conducted using a national database of patients covered by the National Health Security Office, hospitalised between 2014 and 2018. Data included all patients over 18 having a primary diagnosis of SSc (ICD-10: M34). Spatial resources used map information based on GPS coordinates of Thailand. Aerosol components-including organic carbon, black carbon, dust particulate matter diameter < 2.5 µm (PM2.5), and sulfate-were assessed using the NASA satellite MERRA-2 Model M2TMNXFLX v5.12.4. Spatial modelling with R Package Integrated Nested Laplace Approximation (R-INLA) was used to analyse the association between the incidence of mortality and the 5-year accumulation of each aerosol component adjusted by age, sex, and comorbid diseases. The study included 2,094 SSc patients with 3,684 admissions. Most (63.8%) were female. During admission, 1,276 cases died. R-INLA analysis indicated an increase of 1 µg/m
Identifiants
pubmed: 33846466
doi: 10.1038/s41598-021-87114-0
pii: 10.1038/s41598-021-87114-0
pmc: PMC8042026
doi:
Substances chimiques
Aerosols
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7983Références
Ann Rheum Dis. 2011 Jan;70(1):104-9
pubmed: 20679474
J Cell Mol Med. 2009 Nov-Dec;13(11-12):4484-91
pubmed: 19292733
Mod Rheumatol. 2020 Nov;30(6):1025-1032
pubmed: 31813338
J Environ Sci (China). 2015 May 1;31:146-53
pubmed: 25968268
Int J Rheum Dis. 2017 Oct;20(10):1572-1581
pubmed: 28296274
Heliyon. 2020 Feb 08;6(2):e03337
pubmed: 32072045
Occup Environ Med. 2004 Feb;61(2):157-62
pubmed: 14739382
Sci Rep. 2014 Jul 01;4:5509
pubmed: 24981315
Environ Res. 2002 Sep;90(1):1-5
pubmed: 12359184
Int J Rheum Dis. 2016 Mar;19(3):312-20
pubmed: 25293362
Chest. 2015 Feb;147(2):465-474
pubmed: 25275573
Occup Environ Med. 2012 Dec;69(12):908-15
pubmed: 23085558
Crit Rev Toxicol. 2007;37(6):461-87
pubmed: 17661213
Autoimmun Rev. 2011 Nov;11(1):14-21
pubmed: 21763467
Clin Rheumatol. 2017 Mar;36(3):569-582
pubmed: 28091808
Int J Rheumatol. 2016;2016:5356307
pubmed: 27847517
Environ Res. 2020 Feb;181:108891
pubmed: 31740036
Lancet Oncol. 2013 Aug;14(9):813-22
pubmed: 23849838
Int J Rheum Dis. 2020 Jul;23(7):945-957
pubmed: 32420701
Clin Rheumatol. 2013 Mar;32(3):361-7
pubmed: 23224269
Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):191-6
pubmed: 12646506
Int J Environ Res Public Health. 2017 Oct 26;14(11):
pubmed: 29072596
Epidemiology. 2017 Oct;28 Suppl 1:S54-S59
pubmed: 29028676
Front Immunol. 2017 Jun 30;8:763
pubmed: 28713383
Oncotarget. 2016 Apr 12;7(15):20691-703
pubmed: 26942697
Ann Rheum Dis. 1991 Nov;50 Suppl 4:854-61
pubmed: 1750797
BMC Public Health. 2019 Nov 9;19(1):1496
pubmed: 31706295
Clin Occup Environ Med. 2006;5(4):797-815
pubmed: 17110293